A multidisciplinary research team at Aarhus University has provided fundamental new insight into the mechanism of the medical drug dimethyl fumarate, which is the active component of important ...
Fumaric acid esters, which are prescribed for the treatment of psoriasis and multiple sclerosis, are considered to have a favorable risk profile. However, treatment-related progressive multifocal ...
Preparations containing various mixtures of fumaric acid esters are prescribed for psoriasis in several countries, in many cases for off-label use, and are regarded as safe. 1 One such preparation is ...
No added benefit of dimethyl fumarate for multiple sclerosis can be determined, as no suitable data are available, neither for a direct nor for an indirect comparison, report researchers. Dimethyl ...
A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis. The ...
XenoPort Announces Initiation of a Phase 1 Clinical Trial of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis XenoPort, Inc. (Nasdaq ...
April 18 (UPI) --A compound from immune cells treats psoriasis in mice, and might also be effective against other autoimmune diseases, including multiple sclerosis, rheumatoid arthritis and lupus, ...
The European Medicines Agency (EMA) today issued updated recommendations on ways to minimize the risk for progressive multifocal leukoencephalopathy with dimethyl fumarate (Tecfidera, Biogen). To date ...
Dimethyl fumarate (DMF) is an immunomodulatory drug used to treat psoriasis and multiple sclerosis, but its mechanism of action is unclear. Reporting in Science, Kornberg et al. show that DMF blocks ...
A multidisciplinary research team has provided fundamental new insight into the mechanism of the medical drug dimethyl fumarate, which is the active component of important treatments for multiple ...
A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis. The ...
XenoPort Announces Initiation of a Phase 1 Clinical Trial of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis XenoPort, Inc. (Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback